Publications by authors named "Xue-Han Bi"

Claim this Profile
A
Anlotinib combined with TQB2450 in patients with platinum-resistant or -refractory ovarian cancer: A multi-center, single-arm, phase 1b trial.
Chun-Yan Lan, Jing Zhao, Fan Yang, Ying Xiong, Rong Li, Xue-Han Bi

Cell Rep Med· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative SCC-Ag as a predictive marker for the use of adjuvant chemotherapy in cervical squamous cell carcinoma with intermediate-risk factors.
Hong-Tao Guo, Xue-Han Bi, Ting Lei, Xiao Lv, Guang Yao

BMC Cancer· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis